SUVEN PHARMACEUTICALS
|
SUVEN PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit Before Tax | ₹560 Cr | ₹668 Cr | ₹468 Cr | ₹405 Cr | ₹158 Cr |
Adjustment | ₹31 Cr | ₹41 Cr | ₹36 Cr | ₹35 Cr | ₹14 Cr |
Changes In working Capital | ₹5.64 Cr | ₹-194 Cr | ₹-12 Cr | ₹54 Cr | ₹-88 Cr |
Cash Flow after changes in Working Capital | ₹597 Cr | ₹514 Cr | ₹492 Cr | ₹493 Cr | ₹83 Cr |
Cash Flow from Operating Activities | ₹451 Cr | ₹330 Cr | ₹383 Cr | ₹407 Cr | ₹50 Cr |
Cash Flow from Investing Activities | ₹-195 Cr | ₹-136 Cr | ₹-311 Cr | ₹-413 Cr | ₹-65 Cr |
Cash Flow from Financing Activities | ₹-236 Cr | ₹-156 Cr | ₹-76 Cr | ₹7.32 Cr | ₹26 Cr |
Net Cash Inflow / Outflow | ₹20 Cr | ₹37 Cr | ₹-4.51 Cr | ₹0.79 Cr | ₹11 Cr |
Opening Cash & Cash Equivalents | ₹45 Cr | ₹7.18 Cr | ₹12 Cr | ₹11 Cr | - |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | - |
Closing Cash & Cash Equivalent | ₹65 Cr | ₹45 Cr | ₹7.18 Cr | ₹12 Cr | ₹11 Cr |
Compare Cashflow Statement of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹16,353.0 Cr | 5.1% | -3.2% | 38.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,311.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,623.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,134.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹97,408.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,794.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 5.1% |
-3.2% |
38.4% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses